IO Biotech Ownership | Who Owns IO Biotech?
IO Biotech Ownership Summary
IO Biotech is owned by 14.98% institutional investors, 5.62% insiders, and 79.40% retail investors. Novo is the largest institutional shareholder, holding 3.81% of IOBT shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 5.99% of its assets in IO Biotech shares.
IOBT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | IO Biotech | 14.98% | 5.62% | 79.40% |
| Sector | Healthcare Stocks | 42.52% | 10.81% | 46.67% |
| Industry | Biotech Stocks | 45.18% | 10.75% | 44.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Novo | 2.51M | 3.81% | $912.27K |
| Bank of america corp /de/ | 1.65M | 2.51% | $1.93M |
| Ikarian capital | 1.53M | 2.32% | $554.05K |
| Marshall wace, llp | 1.05M | 1.60% | $378.95K |
| Alyeska investment group | 987.65K | 1.50% | $1.16M |
| Morgan stanley | 668.40K | 1.01% | $242.70K |
| Boothbay fund management | 591.18K | 0.90% | $214.66K |
| Renaissance | 547.32K | 0.83% | $198.73K |
| Point72 asset management | 250.00K | 0.38% | $90.78K |
| Xtx topco | 179.21K | 0.27% | $65.07K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Novo | 2.51M | 0.06% | $912.27K |
| Ikarian capital | 1.53M | 0.06% | $554.05K |
| Alyeska investment group | 987.65K | 0.01% | $1.16M |
| Xtx topco | 179.21K | 0.00% | $65.07K |
| Boothbay fund management | 591.18K | 0.00% | $214.66K |
| Pks advisory services | 19.50K | 0.00% | $7.08K |
| Virtu financial | 39.06K | 0.00% | $14.00K |
| Hilton capital management | 25.51K | 0.00% | $9.26K |
| Bridgeway capital management | 75.00K | 0.00% | $27.23K |
| Quadrature capital | 83.38K | 0.00% | $30.28K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ikarian capital | 1.53M | 0.06% | 1.53M |
| Boothbay fund management | 591.18K | 0.00% | 591.18K |
| Renaissance | 547.32K | 0.00% | 408.01K |
| Point72 asset management | 250.00K | 0.00% | 250.00K |
| Xtx topco | 179.21K | 0.00% | 150.02K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vivo capital | - | - | -6.17M |
| Samsara biocapital | - | - | -3.64M |
| Pfm health sciences, lp | - | - | -1.97M |
| Armistice capital | - | - | -1.54M |
| Marshall wace, llp | 1.05M | 0.00% | -1.05M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 1.53M | 0.06% | 1.53M | $554.05K |
| Boothbay fund management | 591.18K | 0.00% | 591.18K | $214.66K |
| Point72 asset management | 250.00K | 0.00% | 250.00K | $90.78K |
| Quadrature capital | 83.38K | 0.00% | 83.38K | $30.28K |
| Goldman sachs group | 66.56K | - | 66.56K | $24.17K |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -230.00 |
| Raymond james financial | -1.00K |
| Redwood wealth management group | -4.17K |
| Two sigma securities | -10.38K |
| Hrt financial lp | -12.69K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 20 | -16.67% | 9,870,183 | -43.60% | 14 | 2.12% | 13 | 18.18% | 5 | -16.67% |
| Jun 30, 2025 | 26 | 23.81% | 18,182,707 | -4.64% | 27 | 3.29% | 11 | 175.00% | 8 | - |
| Mar 31, 2025 | 1 | -96.15% | 23,717 | -99.88% | - | 0.00% | 1 | -92.31% | - | -100.00% |
| Dec 31, 2024 | 12 | -36.84% | 9,874,693 | -58.14% | 14 | 1.17% | 7 | -12.50% | - | -100.00% |
| Sep 30, 2024 | 18 | -10.00% | 23,573,928 | -9.96% | 35 | 2.27% | 7 | 16.67% | 2 | -50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| HBM Healthcare Investments AG Ord | 3.94M | 5.99% | - |
| MEDICAL BioHealth EUR Acc | 679.10K | 1.03% | 7.40K |
| Fidelity Select Biotechnology | 314.60K | 0.48% | - |
| Protea Sectoral Biotech Opps IF USD Acc | 91.44K | 0.14% | - |
| Bridgeway Ultra-Small Company Market | 75.00K | 0.11% | - |
| Fidelity Nasdaq Composite Index | 33.31K | 0.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 30, 2025 | Hunter Heidi | - | Buy | $20.88K |
| Dec 23, 2024 | Ahmad Qasim Iftikhar | Chief Medical Officer | Buy | $26.55K |
| Dec 23, 2024 | Zocca Mai-Britt | Chief Executive Officer | Buy | $10.12K |
| Dec 23, 2024 | Sullivan Amy | Chief Financial Officer | Buy | $8.48K |
| Dec 23, 2024 | Smith Devin Whittemore | General Counsel | Buy | $9.72K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 1 | - |
| 2024 Q4 | 4 | - |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 1 |
IOBT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools